Tuesday, December 23, 2025 | 07:33 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India Coronavirus Dispatch: Short dose gap retained despite contrarian data

How concerned should the nation be about Covid variants, study shows high fatality risk after surgery done within 6 weeks of testing positive, and more-news relevant to India's fight against Covid-19

covid vaccine
premium

FILE PHOTO: A healthcare worker using the vials of COVID-19 vaccine during the second phase of the COVID-19 vaccination at Rajiv Gandhi Super Speciality Hospital in New Delhi

Bharath Manjesh New Delhi
Covishield: Govt retains short dose gap despite research to the contrary

Despite results from a new analysis that indicate a longer gap between Covid-19 vaccine doses yields better clinical results, administrators in India reportedly prefer a shorter gap, a report in The Wire said. The analysis—published in the peer-reviewed medical journal The Lancet last month—found that Covishield’s efficacy is 55.1% when its two doses are given less than six weeks apart but 81.3% when administered 12 weeks apart. India is administering Covishield’s doses 28 days apart. The analysis concludes that increasing the gap also increases the vaccine’s immunogenicity—the ability of